The Latest Breaking News from Vaccine

Officials tell nations to take stock of smallpox vaccines and antivirals as cases grow

India also assured the world that it was determined to become the global vaccine capital and it is now in a position to ensure adequate supply to other nations.

Vaccine stocks edged higher Monday after Pfizer said its three-dose Covid vaccine was more than 80% effective in toddlers and infants.

Pfizer Inc. and BioNTech SE said their COVID-19 vaccine was highly effective and prompted a strong immune response in children under age 5, based on early results from a trial that is likely to pave the way for infants and toddlers to finally get immunized.

The FDA has lifted the clinical hold on Ocugen Inc's (NASDAQ:OCGN) Phase 2/3 trial, OCU-002, for Covaxin (BBV152), a whole virus inactivated COVID-19 vaccine candidate.  In April, the agency paused the trials of the shot, Covaxin, after an inspection of a Bharat Biotech facility by the World Health Organization (WHO) revealed deficiencies…

Three doses of Pfizer’s Covid-19 vaccine will offer strong protection for children younger than 5, the company announced on Monday.

Boris Johnson has said that while the virus is rare, it's important to 'keep an eye on it'

MEIGS COUNTY, Tenn. — At a glance, it seemed like a Southern pandemic success story in a most unlikely place.

Pfizer plans to submit new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.

Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.

THE first case of monkeypox has been confirmed in Scotland, as the total grows across the UK.